Cargando…
Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
Recent technical improvements in evaluations of immune cells in situ and immune monitoring of patients with cancer have provided a wealth of new data confirming that immune cells play a key role in human cancer progression. This, in turn, has revived the expectation that immune endpoints might serve...
Autor principal: | Whiteside, Theresa L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656353/ https://www.ncbi.nlm.nih.gov/pubmed/23730621 http://dx.doi.org/10.3389/fonc.2013.00107 |
Ejemplares similares
-
FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022) -
CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021) -
Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021) -
The potential of microRNA carried by small extracellular vesicles in cancer plasma to serve as cancer biomarkers
por: Whiteside, Theresa L.
Publicado: (2023)